{"id":"NCT01244490","sponsor":"Shire","briefTitle":"Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)","officialTitle":"A Phase 3, Randomised, Double-blind, Multicentre, Parallel-group, Placebo- and Active-reference, Dose-optimisation Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01-17","primaryCompletion":"2013-05-01","completion":"2013-05-01","firstPosted":"2010-11-19","resultsPosted":"2014-07-14","lastUpdate":"2021-07-02"},"enrollment":338,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"Extended-release Guanfacine Hydrochloride","otherNames":["Intuniv"]},{"type":"DRUG","name":"Atomoxetine Hydrochloride","otherNames":["Strattera"]},{"type":"DRUG","name":"Placebo Comparator","otherNames":[]}],"arms":[{"label":"Extended-release Guanfacine Hydrochloride","type":"EXPERIMENTAL"},{"label":"Atomoxetine Hydrochloride","type":"OTHER"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"For children and adolescents, how does SPD503 compare to placebo for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).","primaryOutcome":{"measure":"Change From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale-fourth Edition (ADHD-RS-IV) Total Score at Week 10/13 - Last Observation Carried Forward (LOCF)","timeFrame":"Baseline and Up to 10 weeks for children aged 6-12 years and up to 13 weeks for adolescents aged 13-17 years","effectByArm":[{"arm":"Placebo","deltaMin":-15,"sd":1.1612},{"arm":"Guanfacine Hydrochloride","deltaMin":-23.9,"sd":1.1531},{"arm":"Atomoxetine Hydrochloride","deltaMin":-18.8,"sd":1.1549}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"0.017"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":66,"countries":["United States","Austria","Canada","France","Germany","Ireland","Italy","Poland","Romania","Spain","Sweden","Ukraine","United Kingdom"]},"refs":{"pmids":["25453486"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":111},"commonTop":["Somnolence","Headache","Fatigue","Nausea","Abdominal pain"]}}